Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome.

This report will address evidence-based medicine related to obstetric APS, including limitations on our current management, the relationship between antibodies against domain 1 of β2GPI and obstetric morbidity, hydroxychloroquine use in patients with obstetric APS and factors associated with thrombosis after obstetric APS. Finally, future directions for better understanding this complex condition are also reported by the Task Force coordinators. PMID: 32883160 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32883160?dopt=Abstract

Source: Lupus - September 2, 2020 Category: Rheumatology Authors: de Jesús GR, Benson AE, Chighizola CB, Sciascia S, Branch DW Tags: Lupus Source Type: research